Skip to content

Butyl phthalide sodium chloride injection effects on inflammatory factors

Butyl phthalide sodium chloride injection effects on inflammatory factors

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CPR-15007593
Enrollment
Unknown
Registered
2015-12-08
Start date
2010-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction

Interventions

Research Group:Butyl phthalide and sodium chloride injection

Sponsors

Zhuozhou Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 18-80 years old patients with cerebral infarction; 2. Meet the diagnosis standard made by the Fourth National Cerebrovascular Disease Conference (China); 3. Excluded hemorrhagic cerebrovascular disease by imaging examination; 4. NIHSS score more than 4 points; 5. platelet count and coagulation function are all in normal range; 6. nerve function defect does not affect the previous neurological score.

Exclusion criteria

Exclusion criteria: 1. Complicated with severe infection and bleeding tendency; 2. The butylphthalide allergy; 3. Long time lay stay in bed before the onset of cerebral infarction; 4. Patients with swallowing dysfunction before admission; 5. Complicated with pulmonary embolism, myocardial infarction; 6. Patients with severe hepatic and renal failure; 7. Long term application of hormone; 8. With malignant tumor or expected survival time less than 3 months; patient will receives surgery in near future; 9. Pregnancy and lactation woman.

Design outcomes

Primary

MeasureTime frame
C-reactive protein;

Countries

China

Contacts

Public ContactNiu Huiyan
20530151@qq.com+86 13785276093

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026